Role of redox metals, oxidative protein products and antioxidant potentials of thiols in diabetic retinopathy

Journal of Medical Biochemistry

Volumn 31, Issue 2, 2012, Pages 126-130

  Sindhu, Prathima ^a   Shetty, Beena ^a   Sudha, K ^a   Rao, Gayathri ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

diabetic retinopathy; oxidative stress; protein oxidation; thiols

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ALBUMIN; ANTIOXIDANT; COPPER; GLUTATHIONE; IRON; REACTIVE OXYGEN METABOLITE; THIOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMAN; IRON BLOOD LEVEL; MALE; OXIDATION REDUCTION STATE; PROTEIN GLYCOSYLATION; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE;

EID: 84856433128     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-011-0045-z     Document Type: Article

References (40)

1. Kahn SE. The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes. Diabetol 2003;46:3-19.
2. Cutler RG. Oxidative stress profiling part 1. Its potential importance in the optimization of human health. Annals of the New York Academy of Sciences 2005;1055:93-135.
3. Moussa SA. Oxidative stress in Diabetes Mellitus. Ro - ma nian J Biophys 2008;18(3):225-36.
4. Pi J, Baiy, Zhang O, Wong V, Floering LM, Daniel K, Reece JM. Reactive oxygen species as a signal in glucose stimulated insulin secretion. Diabetes 2007;561:783-91.
5. Hetizer T, Finech B, Albers S, Krohn K, Kohlshutter A, Meinertz T. Beneficial effects of alpha lipoic acid and acorbic acid on endothelium dependent, nitric oxide mediated vasodilatation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 2001;31:53-61.
6. Renu AK, Pooi See Chan. Oxidative stress and diabetic retinopathy. Experimental Diabetic Research 2007;12:441-52.
7. Ann VC, Christel VC, Albert RL. Impact of diabetes mellitus on the relationship between iron, inflammatory and oxidative stress status. Diabetes/Metabolism Re - search and reviews 2006;22:444-54.
8. Sarkar A, Dash S, Barik BK, Muttigi MS, Kedage V, Shetty JK, Prakash M. Copper and ceruloplasmin levels in relation to total thiols and GST in type 2 diabetes mellitus patients. IJCB 2010;25(1):74-6.
9. Cunningham J, Leffell M, Mearkle P, Harmatz P. Elevated plasma ceruloplasmin in insulin dependent diabetes melli tus. Evidence for increased oxidative stress as a va - riable complication. Metabolism 1995;44(8):996-9.
10. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxi - dative stress and stress activated signaling pathways. A unifying hypothesis of type 2 diabetes mellitus. Endo Rev 2002;23:599-622.
11. Guistarini D, Dalle Donne I, Lorenzini S, et al. Age related influence on thiol disulfide and protein mixed disulphide levels in human plasma. J Gerontola 2006;61:1030-8.
12. Baskol G, Gumus K, Oner A, Arda H, Karakucuk S. The role of advanced oxidation protein products and total thiols in diabetic retinopathy. Eur J Ophthal 2008;18(5):792-8.
13. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. 1999;1-59.
14. Witko S V, Friedlander M, Khoa TN, Canteloup S, Dayer JM, Jungers TD. AOPP as a normal mediator of in - flammation and monocyte activation in chronic renal failure. J Immunology 1998;161:2524-32.
15. Varley RH, Gowenlock AH. Proteins. Practical Clinical Biochemistry 1953;1:545-7.
16. Ellman GL. Measurement of total thiols in plasma. Arch Biochem Biophysics 1959;82:70.
17. Varley RH, Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Clini Lab Med 1963;61:883-7.
18. Ramsay W N M. The determination of iron in blood plasma or serum. Clin Chim Acta 1957;2:214.
19. Prakash M, Shetty JK. A modified spectrophotometric micro-method to determine serum copper. Asian J Biochem 2008;3(1):38-42.
20. Drysdale J, Arosio P, Invernizzi R. Mitochondrial ferritin: A new player in iron metabolism. Blood Cells Molecules and Diseases 2002;29:376-83.
21. Yamagishi SI, Ueda S, Matsui T, Nakamura K, Okuda S. Role of advanced glycation end products and oxi da tive stress in diabetic retinopathy. Current Pharma ce uti cal Design 2008;12:962-8.
22. Srivatsan R, Das S, Gadde R, et al. Antioxidants and lipid peroxidation status in diabetic patients with and with out complications. Arch Iran Med 2009;12:121-7.
23. Stadtman RL, Levine RL. Protein oxidation. Ann New York Academy of Science 2000;889:191-208.
24. Kowluru RA, Tangand J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. Diabetes 2001;50:1938-42.
25. Kuroki J, Isshiki K, King GL. Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol 2003;14:216-20.
26. Mukthapura A, Shimogga AS, Sudha VK, Shetty B V, Rao GM. Oxidative products of proteins and antioxidant potential of thiols in gastric carcinoma patients. Journal of Medical Biochemistry 2010;29(2):1-5.
27. Harnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 2000;23(2):234-40.
28. Zeng J, Davies MJ. Protein and low molecular mass thiols as targets and inhibitors of glycation reactions. Chem Res Toxicol 2006;19:1668-76.
29. Hong Zhi Pan, Hong Zang, Dong Chang, Hui Li, Hong Sui. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthal 2008;925:548-51.
30. Ciudin A, Hernández C, Simó R. Iron overload in dia betic retinopathy: A cause or a consequence of im pai red mechanism. Experimental Diabetic Re search 2010;20:714-18.
31. Ishizaka N, Saito K, Furuta K, et al. Angiotensin II-in - du ced regulation of the expression and localization of iron metabolism-related genes in the rat kid ney. Hypertension Research 2007;30(2):195-202.
32. Qiuju L, Liang S, Yi T, Guanjun W, Xu L, Lu C. Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Current Medicinal Chemistry 2009;16(1):113-29.
33. Gao BB, Chen X, Timothy N, Aiello L P, Feener e P. Chara cterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with pro li f - erative diabetic retinopathy. Journal of Proteome Re - search 2008;7(6):2516-25.
34. Yamagishi SI, Ueda S, Matsui T, Nakamura K, Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Current Pharmaceutical Design 2008;14(10):9105.
35. Yang Zheng, Xiao-Kun Li, Yuehui Wang. The Role of Zinc, Copper and Iron in the Pathogenesis of Diabetes and Diabetic Complications: Therapeutic Effects by Chelators. Hemoglobin 2008;32:135-45.
36. Sulochana KN, Coral K, Punitham R, Sharma T, Kasi-nathan N, Ramakrishnan S. Trace elements iron, cop - per and zinc in vitreous of patients with various vitro - retinal diseases. Indian J Ophthal 2004;52:145-8.
37. Shetty JK, Prakash M, Ibrahim SM. Relationship be - tween free iron and glycated hemoglobin in uncon - trolled type 2 diabetes mellitus patients associated with complications. Ind J Biochemistry 2008;23:67-70.
38. Gillery P. Nonenzymatic post-translational modification derived products: New biomarkers of protein aging. Journal of Medical Biochemistry 2011;30:201-6.
39. Aslan D. Biomarkers for diabetes complications: The results of several clinical studies. Journal of Medical Biochemistry 2011;30:207-12.
40. Kartikasari A e R, Georgiou NA, Visseren F L J, Kats RH, Asbeck BS, Marx J J M. Intracellular labile iron modu - lates adhesion of human monocytes to human endo - the lial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2004;24(12):2257-62.